Digital Mental Health Tools and AI Therapy Chatbots: A Balanced Approach to Regulation.
Digital mental health tools (DMHTs) offer a potential solution to overcoming economic, cultural, and geographic barriers to the increasing demand for mental health care, but their adoption raises significant ethical, legal, and social concerns. This article identifies ethical risks related to DMHTs...
| Publicado en: | Hastings Center Report Vol. 55; no. 3; pp. 15 - 30 |
|---|---|
| Autores principales: | , |
| Formato: | Artículo |
| Publicado: |
Wiley-Blackwell
May/Jun2025
|
| Materias: | |
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ssf&AN=186162335&site=ehost-live header: @attributes: shortDbName: ssf uiTerm: 186162335 longDbName: Social Sciences Full Text (H.W. Wilson) uiTag: AN controlInfo: bkinfo: jinfo: jid: 00930334 HCR jtl: Hastings Center Report issn: 00930334 maglogo: Y pubinfo: dt: May/Jun2025 vid: 55 iid: 3 pid: 480 pub: Wiley-Blackwell artinfo: ui: 186162335 10.1002/hast.4979 ppf: 15 ppct: 15 formats: fmt: – @attributes: type: T – @attributes: type: P size: 924KB tig: atl: Digital Mental Health Tools and AI Therapy Chatbots: A Balanced Approach to Regulation. aug: au: Palmer, Amitabha Schwan, David su: United States United States. Food & Drug Administration Mental illness risk factors Mental illness treatment Mental health services Mental health Artificial intelligence Privacy Medical ethics Digital technology Risk assessment Data security Digital health Certification Self medication Telemedicine Chatbots Rules sug: subj: Mental illness risk factors Mental illness treatment Mental health services Mental health Artificial intelligence Privacy Medical ethics United States United States. Food & Drug Administration Offices of Mental Health Practitioners (except Physicians) Residential Mental Health and Substance Abuse Facilities Psychiatric and Substance Abuse Hospitals Other Computer Related Services Computer systems design and related services (except video game design and development) Digital technology Risk assessment Data security Digital health Certification Self medication Telemedicine Chatbots Rules keyword: AI ethics AI regulation bioethics digital mental health mental health therapeutic chatbots AI ethics AI regulation bioethics digital mental health mental health therapeutic chatbots ab: Digital mental health tools (DMHTs) offer a potential solution to overcoming economic, cultural, and geographic barriers to the increasing demand for mental health care, but their adoption raises significant ethical, legal, and social concerns. This article identifies ethical risks related to DMHTs and, in this light, proposes three important criteria for evaluating regulatory approaches. These approaches should (a) ensure widespread access and (b) balance access with risk management while (c) acknowledging preexisting markets and digital self‐medication. Our analysis of three regulatory models—the laissez‐faire approach, a highly regulated approach, and the current U.S. Food and Drug Administration approach—reveals that none satisfactorily balances the promise of access with ethical risks. We therefore suggest modifications to the current FDA approach; these involve a voluntary certification program for nonprescription DMHTs, more‐stringent data safety and privacy practices, easily accessible diagnostic tools, continuous monitoring, and independent audits. These modifications secure the accessibility benefits of DMHTs while mitigating risks associated with widespread use. pubtype: Academic Journal doctype: Article src: R language: English refInfo: copyright: @attributes: flag: N holdings: @attributes: islocal: N |
|---|